Fresenius Medical Care AG income statement FMCQF
In fiscal 2013, which ended Dec 31, 2013, Fresenius Medical Care AG reported revenue of $5.0 billion. Net income was $1.1 billion, a profit margin of 22.3%. Operating income came to $2.3 billion, an operating margin of 45.4%. Diluted earnings per share were $3.65.
USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.
| Line |
FY 2013
Dec 31, 2013
|
FY 2012
Dec 31, 2012
|
FY 2011
Dec 31, 2011
|
FY 2010
Dec 31, 2010
|
FY 2009
Dec 31, 2009
|
|---|---|---|---|---|---|
| Revenue |
4,970
|
—
|
—
|
—
|
—
|
| Cost of revenue |
9,871
+7.3%
|
9,199
+9.3%
|
8,418
+5.1%
|
8,009
+8.0%
|
7,416
|
| Gross profit |
4,738
+3.0%
|
4,601
+10.8%
|
4,152
+8.3%
|
3,835
+0.1%
|
3,832
|
| Research and development |
126
+12.7%
|
112
+0.7%
|
111
+14.8%
|
97
+2.9%
|
94
|
| Selling, general and administrative |
2,392
+7.5%
|
2,225
+11.1%
|
2,002
+9.8%
|
1,824
-8.2%
|
1,987
|
| Operating income |
2,256
+1.7%
|
2,219
+6.9%
|
2,075
+7.9%
|
1,924
+9.6%
|
1,756
|
| Interest income |
39
-12.4%
|
44
-25.7%
|
60
+135.4%
|
25
+18.8%
|
21
|
| Interest expense |
448
-4.9%
|
471
+32.0%
|
356
+16.7%
|
305
-4.9%
|
321
|
| Pretax income |
1,848
-4.4%
|
1,932
+8.6%
|
1,778
+8.2%
|
1,644
+12.9%
|
1,456
|
| Income tax |
592
-2.2%
|
605
+0.7%
|
601
+3.9%
|
578
+17.9%
|
490
|
| Net income |
1,110
-6.5%
|
1,187
+10.8%
|
1,071
+9.5%
|
979
+9.8%
|
891
|
| Basic EPS |
3.65
|
—
|
3.54
+8.9%
|
3.25
+8.7%
|
2.99
|
| Diluted EPS |
3.65
|
—
|
3.51
+8.3%
|
3.24
+8.4%
|
2.99
|
| Weighted average shares, diluted |
303
-0.1%
|
303
+0.7%
|
301
+0.9%
|
298
|
—
|
| Other measures | |||||
| Depreciation and amortization |
648
+7.5%
|
603
+8.2%
|
557
+10.7%
|
503
+10.1%
|
457
|
| EBITDA |
2,904
+2.9%
|
2,821
+7.2%
|
2,632
+8.5%
|
2,427
+9.7%
|
2,213
|
| Interest coverage |
5.04x
|
4.72x
|
5.82x
|
6.30x
|
5.46x
|
| Margins | |||||
| Gross margin |
95.33%
|
—
|
—
|
—
|
—
|
| Operating margin |
45.39%
|
—
|
—
|
—
|
—
|
| Pretax margin |
37.17%
|
—
|
—
|
—
|
—
|
| Profit margin |
22.33%
|
—
|
—
|
—
|
—
|
| EBITDA margin |
58.44%
|
—
|
—
|
—
|
—
|
| Effective tax rate |
32.04%
|
31.32%
|
33.80%
|
35.18%
|
33.69%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.
New to this? Read How to Read an Income Statement, With a Real Example.
Company profile
- Industry
- Services-Misc Health & Allied Services, NEC (SIC 8090)
- Listed as
- FMS (NYSE), FMCQF (OTC)
- Headquarters
- Bad Homburg, Germany
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1333141
- Former names
- Fresenius Medical Care AG & Co. KGaA (until Nov 21, 2023)
Other Services-Misc Health & Allied Services, NEC companies
- Davita Inc. DVA
- Sotera Health Co SHC
- Progyny, Inc. PGNY
- agilon health, inc. AGL
- Charming Medical Ltd MCTA
- Viemed Healthcare, Inc. VMD
- Park Dental Partners, Inc. PARK
- Marpai, Inc. MRAI
All 15 Services-Misc Health & Allied Services, NEC companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.